GUSE, JEFFREY – Trademark Portfolio

Entity Type: 01

GUSE, JEFFREY holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include PAGE PET ANAL GLAND EXPRESSION SYSTEM and ASSPRESSIONS WE GET IT, BUTT YOU GOT THIS!. The owner is based in DUNMORE, PA.

108 SHERWOOD AVENUE

DUNMORE, PA 18512

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

GUSE, JEFFREY's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does GUSE, JEFFREY have?

GUSE, JEFFREY has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does GUSE, JEFFREY file in?

GUSE, JEFFREY files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 10 (Medical Apparatus). Class 35 covers advertising; business management; business administration; office functions.

What are GUSE, JEFFREY's most well-known trademarks?

GUSE, JEFFREY's registered trademark portfolio includes well-known marks such as PAGE PET ANAL GLAND EXPRESSION SYSTEM and ASSPRESSIONS WE GET IT, BUTT YOU GOT THIS!. These are among 2 currently registered trademarks in the portfolio.

What is GUSE, JEFFREY's trademark registration success rate?

GUSE, JEFFREY has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.